Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter A. Thompson currently holds 2,469,959 shares of Prevail Therapeutics Inc. (PRVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter A. Thompson has been a net buyer of PRVL stock. They have purchased $196.5M and sold $137.3M worth of shares.
Peter A. Thompson's most recent insider trade was on Jul 7, 2026, when they sold 85,918 shares at $44.86 per share.
Peter A. Thompson serves as Executive at Prevail Therapeutics Inc. (PRVL). They have executed 150 insider transactions totaling $333.8M over their tenure at the company.
Peter A. Thompson holds the position of Executive at Prevail Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Peter A. Thompson has shown a buying trading pattern, with $196.5M in total purchases and $137.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter A. Thompson was on Dec 28, 2023, when they sold $21.9M worth of ALPN shares. This transaction involved 1,195,683 shares at $18.32 per share.
Peter A. Thompson currently owns 2,469,959 shares of Prevail Therapeutics Inc. (PRVL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter A. Thompson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter A. Thompson has 150 Form 4 filings on record as an insider at Prevail Therapeutics Inc..
Set alerts for Peter A. Thompson and 40,000+ other insiders.